Indications for heart transplantation in pediatric heart disease - A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group

Review

关键词: PULMONARY VASCULAR-RESISTANCE;    IDIOPATHIC DILATED CARDIOMYOPATHY;    EXERCISE OXYGEN-CONSUMPTION;    BRAIN NATRIURETIC PEPTIDE;    IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS;    ORTHOTOPIC CARDIAC TRANSPLANTATION;    MECHANICAL CIRCULATORY SUPPORT;    PROTEIN-LOSING ENTEROPATHY;    VENTRICULAR ASSIST DEVICES;    SINGLE-CENTER EXPERIENCE;   

DOI  :  10.1161/CIRCULATIONAHA.106.180449

来源: SCIE

【 摘 要 】

Background - Since the initial utilization of heart transplantation as therapy for end-stage pediatric heart disease, improvements have occurred in outcomes with heart transplantation and surgical therapies for congenital heart disease along with the application of medical therapies to pediatric heart failure that have improved outcomes in adults. These events justify a reevaluation of the indications for heart transplantation in congenital heart disease and other causes of pediatric heart failure. Methods and Results - A working group was commissioned to review accumulated experience with pediatric heart transplantation and its use in patients with unrepaired and/or previously repaired or palliated congenital heart disease (children and adults), in patients with pediatric cardiomyopathies, and in pediatric patients with prior heart transplantation. Evidence-based guidelines for the indications for heart transplantation or retransplantation for these conditions were developed. Conclusions - This evaluation has led to the development and refinement of indications for heart transplantation for patients with congenital heart disease and pediatric cardiomyopathies in addition to indications for pediatric heart retransplantation.

【 授权许可】

Free